THE ASPIRATION OF THE PATENT SYSTEM AND THE CASE OF THERAPEUTIC PRODUCTS FOR NEGLECTED DISEASES

Authors

  • Marcos Vinício Chein Feres Universidade Federal de Juiz de Fora (UFJF)
  • Alan Rossi Silva Universidade Federal de Juiz de Fora (UFJF)

DOI:

https://doi.org/10.21783/rei.v2i2.60

Keywords:

Innovation, Patents, Neglected Diseases, Therapeutic Products

Abstract

This paper aims to investigate whether the morality of a duty imposed by the current patent system is appropriate to its aspiration to promote innovation, especially in the case of research and development (R&D) of new therapeutic products for neglected diseases. Stemming from an analytical and empirical approach, this investigation is based on descriptive inferences, which are built in accordance with indirect data collection and guided by Epstein and King’s rules of inference. The theoretical framework applied to interpret the data collection was extracted from Bankowski’s distinction between the morality of a duty and the morality of aspiration in the act of interpreting a rule. Firstly, it is possible to infer the insufficiency in following the duties imposed by the current patent legal system in order to promote innovation in the case of neglected diseases. Secondly, it is inferable from the collected data that, even within the multiple groups of neglected diseases, there is a hierarchy among those maladies, which emphasize the importance of considering their particularities in the process of elaborating public polices and interpreting the current patent legal system. Finally, it is also possible to conclude that the research and development of new therapeutic products for all kinds of diseases have not mirrored real public health needs.

Downloads

Download data is not yet available.

Author Biographies

Marcos Vinício Chein Feres, Universidade Federal de Juiz de Fora (UFJF)

SJD in Economic Law. Professor at the Universidade Federal de Juiz de Fora Law School and Postgraduate Program in Law and Innovation. Scholarship in Research Productivity (PQ2) at Conselho Nacional de Desenvolvimento Científico e Tecnológico. 

Alan Rossi Silva, Universidade Federal de Juiz de Fora (UFJF)

Undergraduate student in Law at Universidade Federal de Juiz de Fora. Scholarship of Scientific Initiation in PIBIC/AF of the Conselho Nacional de Desenvolvimento Científico e Tecnológico.

References

BANKOWSKI, Zenon. Vivendo Plenamente a Lei: a Lei do Amor e o

Amor pela Lei. Trad. Lucas Dutra Bertolozzo, Luiz Reimer Rodrigues

Rieffel e Arthur Maria Ferreira Neto. Rio de Janeiro, RJ: Elsevier

Campus, 2008.

BARBOSA, Denis Borges. Direito ao Desenvolvimento, Inovação e a

Apropriação das Tecnologias. In: Denis Borges Barbosa, et. al. A

propriedade Intelectual no Século XXI: estudos de direito. Rio de

Janeiro, RJ: Editora Lumen Juris, 2009.

CASTRO, José Flávio de. A relação entre patentes farmacêuticas,

doenças negligenciadas e o programa público brasileiro de produção e

distribuição de medicamentos. 2012. 134 f. Dissertação (Mestrado em

Sociologia) – Faculdade de Ciências e Letras, Universidade Estadual

Paulista, Araraquara/SP. 2012.

CORREA, Carlos María. Trade Related Aspects of Intellectual Property

Rights: a commentary on the TRIPS agreement. New York, NY: Oxford

University Press, 2007.

CORREA, Carlos María. Intellectual Property Rights, the WTO and

Developing Countries: The TRIPS Agreement and Policy Options.

New York, NY: Zed Books Ltd., 2000.

EPSTEIN, Lee; KING, Gary. Pesquisa Empírica em Direito: as regras de

inferência. São Paulo, SP: Direito GV, 2013. Disponível em: <http://bibliotecadigital.fgv.br/dspace/handle/10438/11444>. Acesso em: 21 de outubro de 2016.

ESTUDO de Carga analisa ocorrência de doenças no Estado de Minas

Gerais. Escola Nacional de Saúde Pública (ENSP), 25 set. 2009.

Disponível em: <http://www.ensp.fiocruz.br/portal-ensp/sessoescientificas/detalhes-noticias.php?matid=18276>.

Acesso em: 21 de outubro de 2016.

FERES, Marcos Vinício Chein, et al., A contradição entre a

regulamentação existente e a complexidade dos fatos reais no caso das

drogas para doenças negligenciadas. In: ENCONTRO DE PESQUISA

EMPÍRICA EM DIREITO, 6º, 2016, Canoas/RS (no prelo).

FOOD AND DRUG ADMINISTRATION (FDA), Innovation or

Stagnation: Challenge and Opportunity on the Critical Path to New

Medical Products. Washington, DC: Food and Drug Administration,

Disponível em:

<http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-

b1_05_topic3-tabb.pdf>. Acesso em: 12 ago. 2016.

GOLD, Edward Richard, et. al. Are Patents Impeding Medical Care and

Innovation? PLoS Med, Vol. 7, 1, 2010. Disponível em:

<http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1

>. Acesso em: 29 de março de 2016.

MYCETOMA is added to WHO List of ‘Neglected Tropical

Diseases’: Move helps bring the disease to the attention of governments

and funders. Drugs for Neglected Diseases Initiative (DNDI), Geneva,

mai. 2016. Disponível em: <http://www.dndi.org/2016/mediacentre/press-releases/mycetoma-who-ntd-list-response/>. Acesso em: 22 de outubro de 2016.

ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Primeiro relatório da

OMS sobre doenças tropicais negligenciadas: avanços para superar o

impacto global de doenças tropicais negligenciadas. Brasil, DF:

Organização Pan-Americana Saúde (OPAS), 2012.

ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS), HEALTH

STATISTICS AND INFORMATION SYSTEMS PROGRAM. Metrics:

Disability-Adjusted Life Year (DALY): Quantifying the Burden of

Disease from mortality and morbidity. 2016. Disponível em:

<http://www.who.int/healthinfo/global_burden_disease/metrics_daly/e

n/>. Acesso em: 21 de outubro de 2016.

PEDRIQUE, Belen, et. al. The drug and vaccine landscape for neglected

diseases (2000–11): a systematic assessment. The Lancet Global Health,

Vol. 1, 6, 2013. Disponível em:

<http://www.thelancet.com/journals/langlo/article/PIIS2214-

X(13)70078-0/abstract>. Acesso em: 27 de abril de 2016.

SANTOS, Bruno Eduardo dos; SILVA, Leandro Fonseca da. A cadeia da

inovação farmacêutica no Brasil: aperfeiçoando o marco regulatório.

Brasília, DF: Secretaria de Acompanhamento Econômico (SEAE), 2008.

Disponível em: <http://seae.fazenda.gov.br/central-dedocumentos/documentos-de-trabalho/documentos-de-trabalho2008/DT_47.pdf>. Acesso em: 21 de outubro de 2016.

SOUZA, Wanderley de (Org.). Doenças Negligenciadas. Rio de Janeiro,

RJ: Academia Brasileira de Ciências, 2010. Disponível em:

<http://www.abc.org.br/IMG/pdf/doc-199.pdf>. Acesso em: 20 de outubro de 2016.

Downloads

Published

2017-02-01

How to Cite

Feres, M. V. C., & Silva, A. R. (2017). THE ASPIRATION OF THE PATENT SYSTEM AND THE CASE OF THERAPEUTIC PRODUCTS FOR NEGLECTED DISEASES. JOURNAL OF INSTITUTIONAL STUDIES, 2(2), 756–798. https://doi.org/10.21783/rei.v2i2.60

Issue

Vol. 2 No. 2 (2016)

Section

Articles

License

The authors hold their copyright and concede to the JOURNAL OF INSTITUTIONAL STUDIES the right to the first publication, in accordance with the Creative Commons Attribution license.

Authors are strongly encouraged to publish their manuscripts in other medias, such  as institutional repositories and personal pages. The Journal only requires the credits of the first publication.